Navigation Links
Cambrex To Announce Fourth Quarter 2012 Financial Results On February 6, 2013
Date:2/1/2013

EAST RUTHERFORD, N.J., Feb. 1, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that fourth quarter 2012 financial results will be released on Wednesday, February 6, 2013 after the market closes.

The Company will host a conference call to discuss the financial results.

 Fourth Quarter 2012 Earnings Conference Call When:Thursday, February 7, 2013 at 8:30 a.m. Eastern Time Dial-in:1-800-723-6604 for U.S.1-785-830-7977 for International Passcode:  6398974Dial-in Replay:1-888-203-1112 for U.S.1-719-457-0820 for InternationalPasscode:  6398974Available through Thursday, February 14, 2013Webcast:www.cambrex.com 

About CambrexCambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.


'/>"/>
SOURCE Cambrex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cambrex Reports Third Quarter 2012 Financial Results
2. Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012
3. Cambrex Announces Significant New Supply Agreement
4. Cambrex To Present At Jefferies 2012 Global Healthcare Conference
5. Cambrex Reports First Quarter 2012 Results
6. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
7. iBio Announces At-the-Market Equity Offering
8. Pharmaceuticals Announces $1.5 Million Second Closing in Private Placement
9. Cardica Announces Fiscal 2013 Second Quarter Financial Results
10. Oclaro Announces Second Quarter Fiscal Year 2013 Financial Results
11. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):